Friday, 1 December 2017

FDA approves Mylan's biosimilar of Roche's breast cancer treatment

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Roche's blockbuster breast cancer treatment Herceptin.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)